Literature DB >> 20145926

Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy.

Lin Wang1, Jin Gu.   

Abstract

OBJECTIVE: This retrospective study was designed to analyze the risk factors for symptomatic leakage after low anterior resection (LAR) for patients with rectal cancer who received 30 Gy/10 f/2 w preoperative radiotherapy.
METHODS: From April 2002 to December 2008, a total of 223 patients with mid-low rectal cancer received 30 Gy/10 f/2 w preoperative radiotherapy and underwent LAR. Six patients were excluded for positive air test, incomplete anastomotic rings, or other major adverse intraoperative events. In the 217 patients with satisfactory anastomoses, 15 probably factors relating to anastomotic leakage were recorded and statistically analyzed.
RESULTS: The median patient age was 57 years, and 48% were women. The median level of anastomosis was 6 cm, median operating time was 130 minutes, and intraoperative blood loss was 200 ml. The symptomatic leakage rate was 11.5% (25/217). Multivariable analysis demonstrated that male gender (odds ratio (OR) = 2.63; p = 0.0474), level of anastomosis < or =4 cm (OR = 8.80; p = 0.038), no defunctioning stoma (OR = 3.80; p = 0.038), and blood loss >200 ml (OR = 3.32; p = 0.080) were the independent risk factors for anastomotic leakage.
CONCLUSIONS: For patients with rectal cancer treated with preoperative radiotherapy and low anterior resection, the risk factors for anastomotic leakage are male gender, lack of defunctioning stoma, level of anastomosis < or =4 cm, and blood loss >200 ml. A defunctioning stoma can decrease the occurrence of symptomatic anastomotic leakage and should be routinely performed in all low anterior resections after 30 Gy/10 f/2 w preoperative radiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 20145926     DOI: 10.1007/s00268-010-0449-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  46 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients.

Authors:  M T Eriksen; A Wibe; J Norstein; J Haffner; J N Wiig
Journal:  Colorectal Dis       Date:  2005-01       Impact factor: 3.788

3.  Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Junji Kishimoto; Hirokazu Nagawa
Journal:  J Am Coll Surg       Date:  2006-01-04       Impact factor: 6.113

4.  Anastomotic leakage and functional outcome after anterior resection of the rectum.

Authors:  O Hallböök; R Sjödahl
Journal:  Br J Surg       Date:  1996-01       Impact factor: 6.939

5.  Diverting stoma after low anterior resection: more arguments in favor.

Authors:  Alexis B Ulrich; Christoph Seiler; Nuh Rahbari; Jürgen Weitz; Markus W Büchler
Journal:  Dis Colon Rectum       Date:  2009-03       Impact factor: 4.585

6.  Risk factors for anastomotic leakage after low anterior resection with total mesorectal excision.

Authors:  W I Law; K W Chu; J W Ho; C W Chan
Journal:  Am J Surg       Date:  2000-02       Impact factor: 2.565

7.  Pelvic drainage and other risk factors for leakage after elective anterior resection in rectal cancer patients: a prospective study of 978 patients.

Authors:  Chien Yuh Yeh; Chung Rong Changchien; Jeng-Yi Wang; Jinn-Shiun Chen; Hong Hwa Chen; Jy-Ming Chiang; Reiping Tang
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

8.  Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer.

Authors:  Kenneth G Walker; Stephen W Bell; Matthew J F X Rickard; Daniel Mehanna; Owen F Dent; Pierre H Chapuis; E Leslie Bokey
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  The incidence and causes of permanent stoma after anterior resection.

Authors:  C M H Bailey; J M D Wheeler; M Birks; R Farouk
Journal:  Colorectal Dis       Date:  2003-07       Impact factor: 3.788

10.  Early postoperative results of surgery for rectal carcinoma as a function of the distance of the tumor from the anal verge: results of a multicenter prospective evaluation.

Authors:  Frank Marusch; Andreas Koch; Uwe Schmidt; Hubertus Wenisch; Michael Ernst; Thomas Manger; Stefanie Wolff; Matthias Pross; Jörg Tautenhahn; Ingo Gastinger; Hans Lippert
Journal:  Langenbecks Arch Surg       Date:  2002-06-15       Impact factor: 3.445

View more
  22 in total

1.  Predicting and preventing anastomotic leakage after low anterior resection for rectal cancer.

Authors:  Christof Hottenrott
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy.

Authors:  Lin Wang; Zhi-Wei Zhai; Deng-Bo Ji; Zhong-Wu Li; Jin Gu
Journal:  Int J Colorectal Dis       Date:  2015-05-03       Impact factor: 2.571

3.  Rectoseminal vesicle fistula as a rare complication after low anterior resection: a report of three cases.

Authors:  Kentaro Nakajima; Masanori Sugito; Yuji Nishizawa; Masaaki Ito; Akihiko Kobayashi; Yusuke Nishizawa; Takanori Suzuki; Toshiyuki Tanaka; Toru Etsunaga; Norio Saito
Journal:  Surg Today       Date:  2012-10-10       Impact factor: 2.549

4.  The REAL (REctal Anastomotic Leak) score for prediction of anastomotic leak after rectal cancer surgery.

Authors:  A Arezzo; M Migliore; P Chiaro; S Arolfo; C Filippini; D Di Cuonzo; R Cirocchi; M Morino
Journal:  Tech Coloproctol       Date:  2019-06-25       Impact factor: 3.781

5.  Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin.

Authors:  Lin Wang; Guo-Li Gu; Zhong-Wu Li; Yi-Fan Peng; Jin Gu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

6.  Clinicopathological outcomes of preoperative chemoradiotherapy using S-1 plus Irinotecan for T4 lower rectal cancer.

Authors:  Naohito Beppu; Hidenori Yoshie; Fumihiko Kimura; Tsukasa Aihara; Hiroshi Doi; Norihiko Kamikonya; Nagahide Matsubara; Naohiro Tomita; Hidenori Yanagi; Naoki Yamanaka
Journal:  Surg Today       Date:  2015-09-12       Impact factor: 2.549

7.  A'high tie'confers an increased risk of anastomotic leakage for lower rectal cancer surgery in patients treated with preoperative radiotherapy.

Authors:  Naohito Beppu; Nagahide Matsubara; Masashi Noda; Fumihiko Kimura; Naoki Yamanaka; Hidenori Yanagi; Naohiro Tomita
Journal:  Surg Today       Date:  2014-09-11       Impact factor: 2.549

Review 8.  Prediction of anastomotic leak in colorectal cancer surgery based on a new prognostic index PROCOLE (prognostic colorectal leakage) developed from the meta-analysis of observational studies of risk factors.

Authors:  S A Rojas-Machado; M Romero-Simó; A Arroyo; A Rojas-Machado; J López; R Calpena
Journal:  Int J Colorectal Dis       Date:  2015-10-27       Impact factor: 2.571

Review 9.  A systematic review of the literature assessing operative blood loss and postoperative outcomes after colorectal surgery.

Authors:  Maria Charalambides; Athina Mavrou; Thomas Jennings; Michael P Powar; James Wheeler; R Justin Davies; Nicola S Fearnhead; Constantinos Simillis
Journal:  Int J Colorectal Dis       Date:  2021-10-26       Impact factor: 2.571

10.  The C-seal trial: colorectal anastomosis protected by a biodegradable drain fixed to the anastomosis by a circular stapler, a multi-center randomized controlled trial.

Authors:  Ilsalien S Bakker; Annelien N Morks; Henk O Ten Cate Hoedemaker; Johannes G M Burgerhof; Henri G Leuvenink; Rutger J Ploeg; Klaas Havenga
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.